BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: He XX, Shi LL, Qiu MJ, Li QT, Wang MM, Xiong ZF, Yang SL. Molecularly targeted anti-cancer drugs inhibit the invasion and metastasis of hepatocellular carcinoma by regulating the expression of MMP and TIMP gene families. Biochem Biophys Res Commun 2018;504:878-84. [PMID: 30219235 DOI: 10.1016/j.bbrc.2018.08.203] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
Number Citing Articles
1 Wang X, Qian S, Wang S, Jia S, Zheng N, Yao Q, Gao J. Combination of Vitamin C and Lenvatinib potentiates antitumor effects in hepatocellular carcinoma cells in vitro. PeerJ 2023;11:e14610. [PMID: 36718449 DOI: 10.7717/peerj.14610] [Reference Citation Analysis]
2 Serala K, Steenkamp P, Mampuru L, Prince S, Poopedi K, Mbazima V. In vitro antimetastatic activity of Momordica balsamina crude acetone extract in HT-29 human colon cancer cells. Environ Toxicol 2021. [PMID: 34272816 DOI: 10.1002/tox.23333] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Ye J, Qi L, Liang J, Zong K, Liu W, Li R, Feng R, Zhai W. Lenvatinib induces anticancer activity in gallbladder cancer by targeting AKT. J Cancer 2021;12:3548-57. [PMID: 33995632 DOI: 10.7150/jca.50292] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Wei P, Ru D, Li X, Shi D, Zhang M, Xu Q, Zhou H, Wen S. Exposure to environmental bisphenol A inhibits HTR-8/SVneo cell migration and invasion. J Biomed Res 2020;34:369-78. [PMID: 32981897 DOI: 10.7555/JBR.34.20200013] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
5 Wang J, Han Y, Wang M, Zhao Q, Chen X, Liu X. Natural triterpenoid saponin Momordin Ic suppresses HepG2 cell invasion via COX-2 inhibition and PPARγ activation. Toxicology in Vitro 2020;65:104784. [DOI: 10.1016/j.tiv.2020.104784] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
6 Fondevila F, Méndez-Blanco C, Fernández-Palanca P, González-Gallego J, Mauriz JL. Anti-tumoral activity of single and combined regorafenib treatments in preclinical models of liver and gastrointestinal cancers. Exp Mol Med 2019;51:1-15. [PMID: 31551425 DOI: 10.1038/s12276-019-0308-1] [Cited by in Crossref: 36] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
7 Li QT, Feng YM, Ke ZH, Qiu MJ, He XX, Wang MM, Li YN, Xu J, Shi LL, Xiong ZF. KCNN4 promotes invasion and metastasis through the MAPK/ERK pathway in hepatocellular carcinoma. J Investig Med 2020;68:68-74. [PMID: 31431469 DOI: 10.1136/jim-2019-001073] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]
8 Al-salama ZT, Syed YY, Scott LJ. Lenvatinib: A Review in Hepatocellular Carcinoma. Drugs 2019;79:665-74. [DOI: 10.1007/s40265-019-01116-x] [Cited by in Crossref: 69] [Cited by in F6Publishing: 56] [Article Influence: 17.3] [Reference Citation Analysis]